Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04927884
Title A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmunityBio, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.